EnsoData raised $20 million in Series B funds for its AI-powered sleep diagnostics. The company’s technology aims to help clinicians diagnose sleep disorders faster and more consistently. The post EnsoData Snags $20M to Improve Sleep Disorder Diagnostics appeared first on MedCity News.
Novavax’s partnership with Sanofi allows the pharma giant to explore potential combinations of assets from both companies, and it’s a blueprint for the kinds of alliances the vaccine developer is pursuing. Rather than commercializing vaccines, Novavax aims to turn its research into business development deals, R&D executive Ruxandra Draghia-Akli said. The post Novavax Sees Sanofi…
There are two changes that could transform the entire system. If we can do these two things, the entire market improves. Not everyone will win, but the good products, the good distributors and the good platforms will rise to the top. The post How More Competition and Better Connected Data Will Solve Healthcare’s Billion Dollar…
To any father that’s struggling right now, know this: your past doesn’t have to write your future. Help is out there, and you can change the trajectory of your life and that of your family. The post A Father’s Promise: Breaking the Cycle of Trauma and Addiction for My Son appeared first on MedCity News.
[Sponsored] A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats. The post Hackers Use AI to Amplify Email Security Threats to Healthcare appeared first on MedCity News.
Health system performance has splintered into three distinct groups — leaders, strugglers and those stuck in the middle, according to Fitch Ratings’ Kevin Holloran. At the HFMA Annual Conference, he and Mayo Clinic CFO Dennis Dahlen discussed how technology and innovation are accelerating this divide. The post The Hospital Word Has Become a Tale of…
Novo Nordisk is ending its partnership with Hims & Hers due to concerns over its practices related to compounded GLP-1s. The post Why Novo Nordisk Is Dropping Its Collaboration with Hims & Hers appeared first on MedCity News.
Nektar Therapeutics’ biologic drug rezpegaldesleukin take a new approach to atopic dermatitis, or eczema, stimulating proliferation of immune cells that tamp down excessive immune responses. The drug met the goals of a Phase 2b study, but analysts note that cross-trial measures show those results are short of the marks achieved by Dupixent, the top biologic…
[Sponsored] Explore how integrated workflow solutions—powered by Veradigm’s suite of products—can transform your operations into a more efficient, connected healthcare system. The post From Data Silos to Integrated Care: Driving Provider Engagement appeared first on MedCity News.
[Sponsored] Unlike inpatient recovery, which requires you to live at a facility full-time, outpatient care allows you to continue working and maintain important relationships while getting necessary care. The post Your Guide to Outpatient Addiction Treatment: Top Choices in Sacramento and Beyond appeared first on MedCity News.